Danaher

Was GE’s New CFO a Risky Choice?
Strategy

Was GE’s New CFO a Risky Choice?

Carolina Dybeck Happe's background makes her an unusual choice to run finance at the struggling conglomerate, a research report suggests.
By David McCann | January 10, 2020
Read More
GE Stock Surges on News of Biopharma Sale
Turnarounds

GE Stock Surges on News of Biopharma Sale

The $21 billion sale to Danaher is a "pivotal milestone" in GE's plan to reduce debt and strengthen its balance sheet, CEO Larry Culp says.
By Matthew Heller | February 25, 2019
Read More
Why You Should Bring Customers to the M&A Table
M&A

Why You Should Bring Customers to the M&A Table

Deal-makers often don’t consider customers, according to a global branding consultancy. When they do, everybody wins.
By Sam Walter and Josh Feldmeth | September 6, 2018
Read More